Home
About
Overview
Sharing Data
ORCID
Help
History (6)
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization: risk factors for one-year recurrence and two-year mortality (preliminary data).
Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols.
The emergence of networks in human genome epidemiology: challenges and opportunities.
A preliminary diagnostic accuracy study of quantitative MRI biomarkers for differentiating parotid tumor types.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (54)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Institution
Department
Faculty Rank
Name
Institution
Why
Elbert Huang
University of Chicago
Why?
Daniel West
University of Chicago
Why?
Ali Cinar
University of Chicago
Why?
Andrew Davis
University of Chicago
Why?
Ameera Haamid
University of Chicago
Why?
Louis Philipson
University of Chicago
Why?
Siri Atma W. Greeley
University of Chicago
Why?
Michael Ujiki
University of Chicago
Why?
Susan Sam
University of Chicago
Why?
Kenneth S. Polonsky
University of Chicago
Why?
Christos Lazaridis
University of Chicago
Why?
Edwin L. Kaplan
University of Chicago
Why?
John Kapoor
University of Chicago
Why?
Graeme Bell
University of Chicago
Why?
Michelle Lemelman
University of Chicago
Why?
Per Page
15
25
50
100
Page
of 4
Next
Prev
Search Criteria
Hypoglycemia
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions